Decoy Therapeutics Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $1.0M
- Price
- $1.53
- % Change (Daily % change from the live per-ticker quote feed.)
- -1.29%
- Volume
- 42.2K
About
Based in Cambridge, Massachusetts, Decoy Therapeutics Inc. is an early-stage biotechnology firm dedicated to tackling critical unmet medical needs. The company employs cutting-edge machine learning and AI technologies, alongside accelerated synthesis methods, to swiftly design, engineer, and manufacture innovative peptide conjugate drug candidates.
Quick stats
Shares outstanding655.2K
Computed float530.7K
Float / shares81.0%
Cash runway (months)7.9
Key info
SectorHealthcare
IndustryBiotechnology
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001615219
Websitehttps://decoytx.com
AI Summary
AI-generated1/19
minorneutralother
The Small Cap Showcase Highlights 8 Public Companies at Their Investor Conference Today
The Small Cap Showcase is hosting an investor conference in New York City on October 1, 2026, featuring presentations from eight micro and small cap public companies, including ACCESS Newswire (NYSE: ACCS) presenting at 3:00 PM ET.
ACCES's presentation, along with the other company webcasts, is available to registered attendees via the conference website and provided links.
The event includes one-on-one meetings with qualified investors and a lunch talk on the IPO market, but contains no new company-specific financial or operational disclosure.